KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Shares Outstanding (2016 - 2025)

HCA Healthcare (HCA) has disclosed Shares Outstanding for 16 consecutive years, with $224.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding fell 10.15% to $224.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $224.6 million, a 10.15% decrease, with the full-year FY2025 number at $224.6 million, down 10.15% from a year prior.
  • Shares Outstanding was $224.6 million for Q4 2025 at HCA Healthcare, down from $229.8 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $333.7 million in Q1 2021 to a low of $224.6 million in Q4 2025.
  • A 5-year average of $273.3 million and a median of $270.9 million in 2023 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: decreased 1.15% in 2021, then dropped 11.1% in 2022.
  • HCA Healthcare's Shares Outstanding stood at $305.5 million in 2021, then decreased by 9.2% to $277.4 million in 2022, then dropped by 4.27% to $265.5 million in 2023, then fell by 5.86% to $250.0 million in 2024, then decreased by 10.15% to $224.6 million in 2025.
  • Per Business Quant, the three most recent readings for HCA's Shares Outstanding are $224.6 million (Q4 2025), $229.8 million (Q3 2025), and $236.1 million (Q2 2025).